Mohammad Fathalipour

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Venues

Hormozgan University of Medical Sciences

Shiraz University of Medical Sciences Medical School (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hormozgan University of Medical Sciences Feb 01 2019

Iraq

Assistant Professo :: Department of Toxicology and Pharmacolog

Education History

Shiraz University of Medical Sciences Medical School Feb 04 2014 - Aug 01 2019

Iran

PHD :: Pharmocology

Publications

Fatemeh Fathi, Ali Ameri, Omid Safa, Mehdi Hassaniazad, Mohammad Fathalipour
Evaluation of short-term adverse events of COVID-19 vaccines: An observational study. Medicine 103 (8) (2024)
Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, Omid Safa, Mehdi Hassaniazad, Mohsen Parsaii, Behnoosh Heidari, Soheil Hassanipour, Boshra Akhlaghi, Mohammad Fathalipour
The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial. Medicine 103 (22) (2024)
Ali Ameri, Farnaz Pourseyedi, Parivash Davoodian, Omid Safa, Soheil Hassanipour, Mohammad Fathalipour
Efficacy and safety of deferoxamine in moderately ill COVID-19 patients: An open label, randomized controlled trial. Medicine 103 (34) (2024)
Ali Ameri, Farnaz Pourseyedi, Parivash Davoodian, Omid Safa, Soheil Hassanipour, Mohammad Fathalipour
Efficacy and safety of deferoxamine in moderately ill COVID-19 patients: An open label, randomized controlled trial. Medicine 103 (34) (2024)
Fatemeh Fathi, Ali Ameri, Omid Safa, Mehdi Hassaniazad, Mohammad Fathalipour
Evaluation of short-term adverse events of COVID-19 vaccines: An observational study. Medicine 103 (8) (2024)
Ali Ameri, Farnaz Pourseyedi, Parivash Davoodian, Omid Safa, Soheil Hassanipour, Mohammad Fathalipour
Efficacy and safety of deferoxamine in moderately ill COVID-19 patients: An open label, randomized controlled trial. Medicine 103 (34) (2024)
Fatemeh Fathi, Ali Ameri, Omid Safa, Mehdi Hassaniazad, Mohammad Fathalipour
Evaluation of short-term adverse events of COVID-19 vaccines: An observational study. Medicine 103 (8) (2024)
Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, Omid Safa, Amin Kusha, Habib Dadvand, Soheil Hassanipour, Mohammad Fathalipour
Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial. Inflammopharmacology (2023)
Mehdi Hassaniazad, Hossein Farshidi, Abdollah Gharibzadeh, Ali Bazram, Elham Khalili, Afsaneh Noormandi, Mohammad Fathalipour
Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19: A randomized clinical trial. Journal of medical virology 94 (7) (2022)
Soheil Hassanipour, Morteza Arab-Zozani, Bahman Amani, Forough Heidarzad, Mohammad Fathalipour, Rudolph Martinez-de-Hoyo
Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials. Scientific reports 12 (1) (2022)
Fariborz Mansour-Ghanaei, Behnam Masihipour, Mohammad Fathalipour, Soheil Hassanipour, Homayoon Sokhanvar, Alireza Mansour-Ghanaei, Mehrnaz Asgharnezhad, Farahnaz Joukar
The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Ali Ameri, Masoomeh Frouz Asadi, Ava Ziaei, Majid Vatankhah, Omid Safa, Manoochehr Kamali, Mohammad Fathalipour, Masoumeh Mahmoodi, Soheil Hassanipour
Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial. Inflammopharmacology (2022)
Aida Doostkam, Mohammad Fathalipour, Mohammad Hossein Anbardar, Azar Purkhosrow, Hossein Mirkhani
Therapeutic Effects of Milk Thistle ( Silybum marianum L.) and Artichoke ( Cynara scolymus L.) on Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Rats. Canadian journal of gastroenterology & hepatology 2022 (2022)
Fariborz Mansour-Ghanaei, Behnam Masihipour, Mohammad Fathalipour, Soheil Hassanipour, Homayoon Sokhanvar, Alireza Mansour-Ghanaei, Mehrnaz Asgharnezhad, Farahnaz Joukar
The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Soheil Hassanipour, Morteza Arab-Zozani, Bahman Amani, Forough Heidarzad, Mohammad Fathalipour, Rudolph Martinez-de-Hoyo
The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials. Scientific reports 11 (1) (2021)
Fatemeh Sadat Hosseini, Alireza Malektojari, Sara Ghazizadeh, Mehdi Hassaniazad, Parivash Davoodian, Habib Dadvand, Amin Reza Nikpoor, Sara Nikoofal-Sahlabadi, Sara Kahoori, Mojtaba Sepandi, Soheil Hassanipour, Mohammad Fathalipour
The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials 22 (1) (2021)
Ali Ameri, Masoomeh Frouz Asadi, Manoochehr Kamali, Majid Vatankhah, Ava Ziaei, Omid Safa, Masoomeh Mahmudi, Mohammad Fathalipour
Evaluation of the effect of melatonin in patients with COVID-19-induced pneumonia admitted to the Intensive Care Unit: A structured summary of a study protocol for a randomized controlled trial. Trials 22 (1) (2021)
Ava Ziaei, Parivash Davoodian, Habib Dadvand, Omid Safa, Soheil Hassanipour, Mahmoud Omidi, Moein Masjedi, Fahime Mahmoudikia, Bahareh Rafiee, Mohammad Fathalipour
Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials 21 (1) (2020)
Mehdi Hassaniazad, Ali Bazram, Soheil Hassanipour, Mohammad Fathalipour
Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials 21 (1) (2020)
Omid Safa, Mehdi Hassaniazad, Mehdi Farashahinejad, Parivash Davoodian, Habib Dadvand, Soheil Hassanipour, Mohammad Fathalipour
Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials 21 (1) (2020)
Omid Safa, Mehdi Hassani-Azad, Mehdi Farashahinejad, Parivash Davoodian, Habib Dadvand, Soheil Hassanipour, Mohammad Fathalipour
Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials 21 (1) (2020)
Mohammad Fathalipour, Hadis Fathalipour, Omid Safa, Peyman Nowrouzi-Sohrabi, Hossein Mirkhani, Soheil Hassanipour
The Therapeutic Role of Carotenoids in Diabetic Retinopathy: A Systematic Review. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)

Mohammad Fathalipour.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad Fathalipour